Mid-Afternoon Market Update: Petmed Rises On Strong Q1 Results; TherapeuticsMD Shares Plunge

Toward the end of trading Monday, the Dow traded down 0.01 percent to 21,005.49 while the NASDAQ gained 0.01 percent to 6,101.30. The S&P also fell, dropping 0.02 percent to 2,398.84.

Leading and Lagging Sectors

Technology sector was the top gainer in the US market on Monday. Top gainers in the sector included Tower Semiconductor Ltd. (USA) TSEM, 3D Systems Corporation DDD, and Microvision, Inc. MVIS.

In trading on Monday, basic materials shares were relative laggards, down on the day by about 0.75 percent. Meanwhile, top losers in the sector included Olympic Steel, Inc. ZEUS, down 4 percent, and Koppers Holdings Inc. KOP, down 10 percent.

Top Headline

Tyson Foods, Inc. TSN posted downbeat earnings for its first quarter on Monday.

Tyson said it earned $1.01 per share in the first quarter on revenue of $9.08 billion; Analysts were expecting the company to earn $1.02 per share on revenue of $9.05 billion.

Tyson Foods expects FY 2017 earnings of $4.90 to $5.05 per share, versus analysts’ estimates of $5.02 per share.

Equities Trading UP

Straight Path Communications Inc STRP shares shot up 32 percent to $213.16. Straight Path Communications disclosed that the $184 per share bid from a multi-national telecom company is superior to AT&T's bid.

Shares of Kosmos Energy Ltd KOS got a boost, shooting up 16 percent to $6.91 after the company posted strong Q1 results. Kosmos Energy also reported a major gas discovery offshore Senegal.

Petmed Express Inc PETS shares were also up, gaining 24 percent to $30.15 after the company posted upbeat quarterly results.

Equities Trading DOWN

Horizon Pharma PLC HZNP shares dropped 34 percent to $10.27 as the company posted downbeat Q1 earnings and lowered its FY 2017 guidance. The company also announced plans to acquire River Vision for $145 million in cash.

Shares of TherapeuticsMD Inc TXMD were down around 11 percent to $4.14 after the company after the company announced it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration. The letter is in response to the company's New Drug Application (NDA) for its investigational applicator-free estradiol vaginal softgel capsule called TX-004HR. TherapeuticsMD said in its press release that while the letter didn't identify any issues related to the efficacy of the therapy, the FDA couldn't approve TX-004HR at this time. Specifically, the FDA cited a lack of long-term endometrial safety data beyond the 12-week period, which was explored in a Phase 3 clinical study called Rejoice Trial.

Innodata Inc INOD was down, falling around 15 percent to $1.65. Innodata reported a Q1 loss of $0.07 per share on sales of $15 million.

Commodities

In commodity news, oil traded down 0.11 percent to $46.17 while gold traded down 0.04 percent to $1,226.40.

Silver traded down 0.09 percent Monday to $16.26, while copper fell 1.48 percent to $2.491.

Eurozone

European shares closed mostly lower today. The eurozone’s STOXX 600 dropped 0.13 percent, the Spanish Ibex Index fell 0.35 percent, while Italy’s FTSE MIB Index slipped 0.26 percent. Meanwhile the German DAX dropped 0.18 percent, and the French CAC 40 declined 0.91 percent while U.K. shares rose 0.05 percent.

Economics

The Consumer Board Employment Trends Index rose to 132.64 for April, versus a prior reading of 131.40.